Skip to content

OUTLOOK THERAPEUTICS, INC.: 10-K filed 2016-12-29

What OUTLOOK THERAPEUTICS, INC. reported in its annual report filed 2016-12-29 (fiscal FY 2016): 41 published measures, 81 facts as tagged in accession 0001571049-16-020882.

This filing

Form
10-K (annual report)
Filed
2016-12-29
Fiscal period
fiscal FY 2016
Accession
0001571049-16-020882 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OUTLOOK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-09-3023,705,934USD
At 2015-09-3035,008,621USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-09-3028,906,112USD
At 2015-09-3062,561,113USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-09-30-5,200,178USD
At 2015-09-30-54,219,386USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-09-302,351,887USD
At 2015-09-309,070,975USD
At 2014-09-302,349,313USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-53,329,262USD366
2014-10-01 to 2015-09-30-47,393,283USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-10-01 to 2016-09-301,098,180USD366
2014-10-01 to 2015-09-308,804,244USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-10-01 to 2016-09-302,979,576USD366
2014-10-01 to 2015-09-305,219,237USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-09-30-147,393,548USD
At 2015-09-30-94,064,286USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-10-01 to 2016-09-30103,000USD366
2014-10-01 to 2015-09-30-190,111USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-09-3016,958,553USD
At 2015-09-3017,759,938USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-10-01 to 2016-09-3012,450,079USD366
2014-10-01 to 2015-09-3011,177,858USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-51,758,312USD366
2014-10-01 to 2015-09-30-46,562,626USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-09-305,678,494USD
At 2015-09-3015,164,233USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-10-01 to 2016-09-301,467,950USD366
2014-10-01 to 2015-09-302,297,339USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-09-3020,436,854USD
At 2015-09-3037,041,599USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-09-305,071,520USD
At 2015-09-3011,563,055USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-09-3020,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-10-01 to 2016-09-3054,737,888USD366
2014-10-01 to 2015-09-3051,781,863USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-10-01 to 2016-09-3033,101,543USD366
2014-10-01 to 2015-09-3038,876,040USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-09-3022,802,778shares
At 2015-09-309,436,294shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-09-30141,965,342USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2016-09-30-5,200,178USD
At 2015-09-30-54,873,803USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2016-09-302,881,481USD
At 2015-09-302,922,764USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-09-3022,920,493USD
At 2015-09-3021,403,385USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-09-305,961,940USD
At 2015-09-303,643,447USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-09-30852,801USD
At 2015-09-30910,224USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-09-30761,334USD
At 2015-09-30284,710USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-09-306,121,942USD
At 2015-09-305,924,648USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-09-303,326,607USD
At 2015-09-301,793,109USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2016-09-301,504,159USD
At 2015-09-30775,625USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-53,226,262USD366
2014-10-01 to 2015-09-30-48,859,965USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-53,329,262USD366
2014-10-01 to 2015-09-30-48,669,854USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-63,166,242USD366
2014-10-01 to 2015-09-30-52,998,402USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2016-09-3021,636,345USD366
2014-10-01 to 2015-09-3012,905,823USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-10-01 to 2016-09-302,394,279USD366
2014-10-01 to 2015-09-301,824,600USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2015-10-01 to 2016-09-30103,000USD366
2014-10-01 to 2015-09-30-190,111USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2015-10-01 to 2016-09-301,477,913USD366
2014-10-01 to 2015-09-301,402,209USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2015-10-01 to 2016-09-303,000USD366
2014-10-01 to 2015-09-302,250USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-10-01 to 2016-09-3016,137,913USD366
2014-10-01 to 2015-09-3041,249,998USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-20,000USD366
2014-10-01 to 2015-09-3020,000USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-10-01 to 2016-09-30-5,326,374USD366
2014-10-01 to 2015-09-306,580,722USD365

Inspect the source

Entity
OUTLOOK THERAPEUTICS, INC. / CIK 0001649989
Captured
2026-09-21T17:23:24.422Z
SEC response SHA-256
ce697e8c1ac203fe6827508f0d6a14f8a445ce42f9c031026a98c3f5635933f0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001649989.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))